knowlabs.co - KNW Total Company Value-to-Revenue Ratio

Know Labs, Inc. (KNW) is developing a revolutionary non-invasive glucose monitoring method utilizing radio-frequency sensors. This enterprise value-to-revenue chart on GURU.Markets helps assess this potential, with the current parameter standing at . The integration of AI into diagnostic devices automates glucose monitoring, reducing the burden on physicians. However, reliance on secondary offerings and challenges with FDA certification create significant financial risks.
Financial and market metric breakdowns for Know Labs Corp (KNW)

Market expectations for Know Labs, Inc. (KNW) are based on the potential of breakthrough technology, making the EV/Sales valuation a key tool for analyzing the investment advance. This indicator compares the total enterprise value, including debt and cash, with revenue volume, reflecting the asset's degree of overheating given the company's dependence on venture capital amidst the high macro-stability of medical developments.